Document Detail

Cytokines and signaling molecules predict clinical outcomes in sepsis.
MedLine Citation:
PMID:  24244449     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: Inflammatory response during sepsis is incompletely understood due to small sample sizes and variable timing of measurements following the onset of symptoms. The vasopressin in septic shock trial (VASST) compared the addition of vasopressin to norepinephrine alone in patients with septic shock. During this study plasma was collected and 39 cytokines measured in a 363 patients at both baseline (before treatment) and 24 hours. Clinical features relating to both underlying health and the acute organ dysfunction induced by the severe infection were collected during the first 28 days of admission.
HYPOTHESIS: Cluster analysis of cytokines identifies subgroups of patients at differing risk of death and organ failure.
METHODS: Circulating cytokines and other signaling molecules were measured using a Luminex multi-bead analyte detection system. Hierarchical clustering was performed on plasma values to create patient subgroups. Enrichment analysis identified clinical outcomes significantly different according to these chemically defined patient subgroups. Logistic regression was performed to assess the importance of cytokines for predicting patient subgroups.
RESULTS: Plasma levels at baseline produced three subgroups of patients, while 24 hour levels produced two subgroups. Using baseline cytokine data, one subgroup of 47 patients showed a high level of enrichment for severe septic shock, coagulopathy, renal failure, and risk of death. Using data at 24 hours, a larger subgroup of 81 patients that largely encompassed the 47 baseline subgroup patients had a similar enrichment profile. Measurement of two cytokines, IL2 and CSF2 and their product were sufficient to classify patients into these subgroups that defined clinical risks.
CONCLUSIONS: A distinct pattern of cytokine levels measured early in the course of sepsis predicts disease outcome. Subpopulations of patients have differing clinical outcomes that can be predicted accurately from small numbers of cytokines. Design of clinical trials and interventions may benefit from consideration of cytokine levels.
Christopher D Fjell; Simone Thair; Joseph L Hsu; Keith R Walley; James A Russell; John Boyd
Related Documents :
22955689 - Elevated serum ykl-40 level predicts myocardial reperfusion and in-hospital mace in pat...
24894049 - Prevalence of essential tremor in an idiopathic parkinson's disease patient population.
7512009 - Impaired granulocyte oxidative burst and decreased expression of leucocyte adhesion mol...
24920609 - Acute ischaemic stroke or transient ischaemic attack and the need for inpatient echocar...
25110759 - Ultrasound evaluation of mediastinal lymphadenopathy in patients with sarcoidosis.
24383519 - The value of serum pepsinogen levels for the diagnosis of gastric diseases in chinese h...
11441639 - Multichannel derived median nerve sep compared to eeg in patients with vascular cerebra...
2309629 - Value of electrophysiologic testing in patients with previous myocardial infarction and...
1138439 - Hl-a antigens and thyrotoxicosis.
Publication Detail:
Type:  Journal Article     Date:  2013-11-14
Journal Detail:
Title:  PloS one     Volume:  8     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2013  
Date Detail:
Created Date:  2013-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e79207     Citation Subset:  IM    
James Hogg Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by...
Next Document:  Affective Compatibility between Stimuli and Response Goals: A Primer for a New Implicit Measure of A...